TITLE

Treatment - Complications

PUB. DATE
June 2010
SOURCE
Current Medical Literature: Breast Cancer;2010, Vol. 22 Issue 2, p66
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers information on research studies on treatment complications in breast cancer published in medical journals as of June 2010, along with commentaries on the research findings. The relationship between circulating tumor cells and increased risk of venous thromboembolism in metastatic breast cancer patients was reported by M. Mego et al. The association between selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen was studied by C. M. Kelly.
ACCESSION #
51782596

 

Related Articles

  • Selective serotonin reuptake inhibitor use during tamoxifen treatment increased risk for breast cancer mortality. Cona, Christen; Harris, Jason; Lawrence, Leah; Southall, Jennifer // Hem/Onc Today;3/25/2010, Vol. 11 Issue 6, p25 

    The article discusses research on the influence of selective serotonin reuptake inhibitor along with tamoxifen on breast cancer mortality, by C. M. Kelly and colleagues, published in the 2010 issue of the "British Medical Journal."

  • SSRI use with tamoxifen.  // Clinical Oncology Alert;Apr2010 Supplement, p1 

    The article discusses research on the role of selective serotonin reuptake inhibitors (SSRI) paroxetine in reducing the effect of tamoxifen in women with breast cancer. It references a study published in the "British Medical Journal." An overview of the research findings is presented. The...

  • Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. Stearns, Vered; Johnson, Michael D.; Rae, James M.; Morocho, Alan; Novielli, Antonella; Bhargava, Pankaj; Hayes, Daniel F.; Desta, Zeruesenay; Flockhart, David A. // JNCI: Journal of the National Cancer Institute;12/3/2003, Vol. 95 Issue 23, p1758 

    Background: Tamoxifen, a selective estrogen receptor modulator (SERM), is converted to 4-hydroxy-tamoxifen and other active metabolites by cytochrome P450 (CYP) enzymes. Selective serotonin reuptake inhibitors (SSRIs), which are often prescribed to alleviate tamoxifen-associated hot...

  • DRUGSCAN: ONCOLOGY. Kanaike, Megumi // Journal of Pharmacy Practice & Research;Jun2010, Vol. 40 Issue 2, p160 

    The article presents summary information on oncology research from international medical literature. Topics include endometrial effects associated with the use of the drugs exemestane or tamoxifen in early breast cancer treatment, survival of biliary tract cancer patients treated with cisplatin...

  • Cytotoxicity of different selective serotonin reuptake inhibitors (SSRIs) against cancer cells. Rosetti, M.; Frasnelli, M.; Tesei, A.; Zoli, W.; Conti, M. // Journal of Experimental Therapeutics & Oncology;2006, Vol. 6 Issue 1, p23 

    Cell membrane ion transporters expression and activity are altered in cancer cells and these phenotypic alterations offer potential targets for cancer therapies. Among the therapeutic agents affecting cell membrane transporters, serotonin reuptake inhibitors (SSRIs) have been shown to have...

  • SSRI use with tamoxifen.  // Primary Care Reports;Apr2010 Pharmacology Watch, p1 

    The article discusses research on selective serotonin reuptake inhibitors (SSRIs) paroxetine (Paxil), an anti-depressant drug that lessens the effect of tamoxifen in women with breast cancer. It references a study published in the "British Medical Journal," wherein the researchers observed more...

  • Tamoxifen, SSRIs, and Breast Cancer Recurrence.  // Clinical Cardiology Alert;Sep2009 Pharmacology Watch, p1 

    The article discusses research on the drug interaction between tamoxifen and selective serotonin reuptake inhibitors (SSRI) antidepressants. It references two studies published in the "Journal of Clinical Oncology." One of the studies suggested that the risk of breast cancer recurrence is...

  • SSRI use with tamoxifen. Elliott, William T. // Clinical Cardiology Alert;Apr2010 Pharmacology Watch, p1 

    The article discusses research being done on the effect of selective serotonin reuptake inhibitor (SSRI) paroxetine with tamoxifen on women with breast cancer. It references a study published in the "British Medical Journal." The study included more than 2,400 women based in Ontario who were...

  • Tamoxifen and CYP2D6 Inhibitors.  // Travel Medicine Advisor;Sep2009 Supplement, p1 

    The article reveals the results of two studies on the potential serious drug interaction between tamoxifen and some commonly used selective serotonin reuptake inhibitor (SSRI) anti depressants. According to the studies, some SSRIs particularly paroxetene and fluxetine are potent inhibitors of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics